ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

NCT01457677 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

357

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Placebo
DRUG: RO4995819
DRUG: RO4995819
DRUG: RO4995819

Sponsor

Hoffmann-La Roche